Skip to main content
T-Therapeutics  I  About

Anastasiya Sybirna

Board Observer

Anastasiya is a healthcare investor with F-Prime Capital based in London. She is a Board Observer for T-Therapeutics, as well as two other F-Prime portfolio companies in the fields of intrinsically disordered proteins and cellular rejuvenation.

Prior to joining F-Prime, Ana was an Engagement Manager at McKinsey specialising in Pharmaceuticals & Medical Products and had previously worked as a Strategy Consultant at Advancy.

Ana holds a Ph.D. in Stem Cell Biology and Medicine from the University of Cambridge (UK), a MSc in Molecular and Cell Biology from École normale supérieure (Paris, France) and a BSc in Biology from Ivan Franko National University of Lviv (Ukraine).

T-Therapeutics
Suite 1
Riverside 3
Granta Park
Cambridge
CB21 6AD